Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

Systemic corticosteroids (SCS) are a highly effective treatment for acute exacerbations and
long-term symptom control in asthma. Long-term SCS use is highly prevalent across all …

The Mass General Brigham Biobank (formerly Partners HealthCare Biobank) is a large
repository of biospecimens and data linked to extensive electronic health record data and …

Rationale: Inhaled corticosteroids (ICSs) are the cornerstone of asthma treatment and
significantly improve morbidity and mortality. Adverse effects of oral corticosteroids are well …

Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid
(ICS)/formoterol have provided new evidence that may warrant a reconsideration of current …

With the expanding landscape of novel therapeutic approaches for pediatric asthma, further
evidence is needed to help clinicians choose the best option for patients, particularly those …

In the present studies, the assessment of how viral exacerbation of asthmatic responses with
and without pulmonary steroid treatment alters the microbiome in conjunction with immune …

Metabolomics and lipidomics have an increasingly pivotal role in drug discovery and
development. In the context of drug discovery, monitoring changes in the levels or …

Background The phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-
blind (DB) study extended understanding of the efficacy of benralizumab for patients with …

Urinary eicosanoid concentrations reflect inflammatory processes in multiple diseases and
have been used as biomarkers of disease as well as suggested for patient stratification in …